We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

When the Trump administration cut more than $11 billion in COVID-era funds to states in late March, addiction recovery programs suffered swift losses. An Indiana organization that employs people ...

Arkansas is appealing the Trump administration’s denial of federal aid for the state’s recovery efforts after a string of deadly and destructive tornado storms. Gov. Sarah Huckabee Sanders (R-Ark.

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

Codelco posted a slight increase in first-quarter output despite power, weather and maintenance interruptions, as the world’s biggest copper producer battles to compensate for deteriorating ore ...

He emphasized the importance of personal responsibility, spiritual awakening and community connection in recovery. He advocated for a multi-pronged approach to the opioid crisis, including ...

Global investors’ rotation out of American assets will go on for years if President Donald Trump persists with his trade policy, according to a strategist who timed the unwind of US ...

Agilent 1290 Infinity II Multisampler is a compact 1300 bar compatible unit handling vials and up to 16 microtiter plates (6,144 samples), cuts cycles times to five seconds, and reduces carryover ...

Agilent J&W HP-5ms Ultra Inert is specifically tested for inertness for active compounds, including acidic and basic compounds, to meet the worldwide drive for lower detection levels. With very ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 ...